These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3106541)

  • 1. [Studies on the hypothalamic-pituitary dopaminergic system in Parkinson's disease and spinocerebellar degeneration. Response to TRH and sulpiride].
    Joshita Y
    Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):59-66. PubMed ID: 3106541
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy.
    Vogel HP; Ketsche R
    J Neurol; 1986 Jun; 233(3):149-52. PubMed ID: 3088217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients.
    Cusimano G; Capriani C; Bonifati V; Meco G
    Acta Neurol Scand; 1991 Mar; 83(3):145-50. PubMed ID: 1903236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of some peptides on dopaminergic function in man.
    Lal S; Nair NP; Isaac I; Thavundayil J; Guyda H
    J Neural Transm Suppl; 1990; 29():173-81. PubMed ID: 2113567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of dopaminergic antagonism by sulpiride on TRH and VIP-induced prolactin release in nonsuckled lactating rats.
    Haisenleder DJ; Moy JA; Lawson DM
    Life Sci; 1990; 46(25):1867-72. PubMed ID: 2163481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of dopamine receptors in young-onset Parkinson's disease: prolactin response.
    Kostic VS; Marinkovic Z; Filipovic S; Momcilovic D
    Mov Disord; 1993 Apr; 8(2):227-9. PubMed ID: 8474497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frequency response analysis of oculomotor functions (II)--Comparative study of Parkinson's disease with spinocerebellar degeneration and normal control].
    Hayashi F; Koike Y; Hibino R; Sakurai N; Sobue I
    Rinsho Shinkeigaku; 1986 Jul; 26(7):665-72. PubMed ID: 3464377
    [No Abstract]   [Full Text] [Related]  

  • 8. [Patients with Parkinson disease: functional analysis of dopamine receptors by bromocriptine- thyrotropin-releasing hormone test].
    Díaz F; Liberman C; Chariá P
    Rev Med Chil; 1991 Mar; 119(3):252-7. PubMed ID: 1842116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of hypothalamic hyperprolactinemia.
    Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
    J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged secretion of prolactin in response to thyrotrophin-releasing hormone after hypothalamo-pituitary disconnection in the ewe.
    Thomas GB; Cummins JT; Hammond JM; Horton RJ; Clarke IJ
    J Endocrinol; 1986 Dec; 111(3):433-8. PubMed ID: 3100711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of Prl release in galactorrhoeic normoprolactinaemic women.
    D'Agata R; Aliffi A; Maugeri G; Mongioì A; Vicari E; Gulizia S
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):1-4. PubMed ID: 6812343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease.
    Izumi Y; Fukuuchi Y; Ishihara N; Imai A; Komatsumoto S
    Tokai J Exp Clin Med; 1995 Dec; 20(4-6):203-8. PubMed ID: 8956461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for dopamine-related and TRH-related pituitary TSH and PRL pools in patients with prolactinoma.
    Hanew K; Utsumi A; Sugawara A; Shimizu Y; Yoshinaga K
    Acta Endocrinol (Copenh); 1991 May; 124(5):545-52. PubMed ID: 1903012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The forgotten effects of thyrotropin-releasing hormone: Metabolic functions and medical applications.
    Fröhlich E; Wahl R
    Front Neuroendocrinol; 2019 Jan; 52():29-43. PubMed ID: 29935915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tartrate thyrotropin-releasing hormone treatment on serum thyrotropin, free triiodothyronine, free thyroxine and prolactin levels in patients with spinocerebellar degeneration.
    Merola B; Colao A; Di Renzo G; Filla A; Campanella G; Lombardi G
    Horm Res; 1992; 38(3-4):160-3. PubMed ID: 1306848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic inhibition of prolactin release from pituitary glands of the domestic fowl incubated in vitro.
    Hall TR; Chadwick A
    J Endocrinol; 1984 Oct; 103(1):63-9. PubMed ID: 6434684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary axis and peripheral tissue responses to TRH stimulation and liothyronine suppression tests in normal subjects evaluated by current methods.
    Dare GL; de Castro M; Maciel LM
    Thyroid; 2008 Apr; 18(4):401-9. PubMed ID: 18399766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin secretion in Parkinson disease.
    Eisler T; Thorner MO; MacLeod RM; Kaiser DL; Calne DB
    Neurology; 1981 Oct; 31(10):1356-9. PubMed ID: 6810204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulpiride and thyrotrophin releasing hormone loading test in patients with acromegaly.
    Zséli J; Földes J; Holló I; Kollin E; Horváth C; Gács G; Borvendég J
    Acta Med Acad Sci Hung; 1980; 37(4):357-64. PubMed ID: 6785978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants.
    Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM
    Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.